Opinion: Should Scientists Engage in Activism?

Scientists who accept funding with the tacit agreement that they keep their mouths shut about the government are far more threatening to an independent academy than those who speak their minds.

Written byAdam Marcus and Ivan Oransky
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

PIXABAY, OPENCLIPARTHave you heard that scientists are planning a march on Washington? The move is not being billed as a protest, but rather as a “celebration of our passion for science and a call to support and safeguard the scientific community,” although it comes as a direct response to recent policy changes and statements by the Trump administration.

Not everyone thinks the nonprotest protest is a good thing. It’s “a terrible idea,” wrote Robert Young, a geologist at Western Carolina University, in The New York Times. The march, Young said, will just reinforce a belief among some conservatives that “scientists are an interest group,” and polarize the issue, making researchers’ jobs more difficult. Others find that argument less than convincing, pointing out that science and politics have always been intertwined.

As the founders of the blog Retraction Watch and the Center for Scientific Integrity, we often see researchers reluctant to push for or embrace change—whether it’s to the conventional way of dealing with misconduct in journals (which for years was basically to not do so) or addressing problems of reproducibility of their experiments. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies